Gaito S, Aznar M C, Burnet N G, Crellin A, France A, Indelicato D, Kirkby K J, Pan S, Whitfield G, Smith E
Proton Clinical Outcomes Unit, The Christie NHS Proton Beam Therapy Centre, Manchester, UK; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Department of Proton Beam Therapy, The Christie Proton Beam Therapy Centre, Manchester, UK.
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Clin Oncol (R Coll Radiol). 2023 Sep;35(9):e528-e536. doi: 10.1016/j.clon.2023.05.014. Epub 2023 May 30.
Proton beam therapy (PBT) is one of the most advanced radiotherapy technologies, with growing evidence to support its use in specific clinical scenarios and exponential growth of demand and capacity worldwide over the past few decades. However, geographical inequalities persist in the distribution of PBT centres, which translate into variations in access and use of this technology. The aim of this work was to look at the factors that contribute to these inequalities, to help raise awareness among stakeholders, governments and policy makers. A literature search was conducted using the Population, Intervention, Comparison, Outcomes (PICO) criteria. The same search strategy was run in Embase and Medline and identified 242 records, which were screened for manual review. Of these, 24 were deemed relevant and were included in this analysis. Most of the 24 publications included in this review originated from the USA (22/24) and involved paediatric patients, teenagers and young adults (61% for children and/or teenagers and young adults versus 39% for adults). The most reported indicator of disparity was socioeconomic status (16/24), followed by geographical location (13/24). All the studies evaluated in this review showed disparities in the access to PBT. As paediatric patients make up a significant proportion of the PBT-eligible patients, equity of access to PBT also raises ethical considerations. Therefore, further research is needed into the equity of access to PBT to reduce the care gap.
质子束治疗(PBT)是最先进的放射治疗技术之一,在过去几十年里,越来越多的证据支持其在特定临床场景中的应用,全球范围内对该技术的需求和治疗能力呈指数级增长。然而,PBT中心的分布存在地域不平等现象,这导致了该技术在获取和使用方面的差异。这项工作的目的是研究导致这些不平等现象的因素,以提高利益相关者、政府和政策制定者的认识。采用人群、干预措施、对照、结局(PICO)标准进行文献检索。在Embase和Medline中使用相同的检索策略,共识别出242条记录,并进行人工筛选。其中,24条记录被认为相关并纳入本分析。本综述纳入的24篇出版物大多来自美国(22/24),涉及儿科患者、青少年和青年(儿童和/或青少年及青年占61%,成人占39%)。报告最多的差异指标是社会经济地位(16/24),其次是地理位置(13/24)。本综述评估的所有研究均显示在获取PBT方面存在差异。由于儿科患者在符合PBT治疗条件的患者中占很大比例,获取PBT的公平性也引发了伦理考量。因此,需要进一步研究PBT获取的公平性,以缩小治疗差距。